You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mitoxantrone

Showing 76 - 100 of 438
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
Apr 6, 2022

Lymphoma Trial in Lyon (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Lymphoma
  • Lyon, France
    Centre Leon Berard
Feb 19, 2021

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Mitoxantrone Hydrochloride, Selinexor)

Completed
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 6, 2020

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
Has Results
  • Prostate Cancer
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 13, 2020

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

Recruiting
  • T-lymphoblastic Lymphoma
  • +5 more
  • BCL2 Inhibitor plus IM2 regimen
  • Shanghai, Shanghai, China
    Shanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

Active, not recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Beijing, China
  • +47 more
Aug 17, 2022

Hodgkin Lymphoma Trial in Spain (BrentuximabVedotin (BV))

Active, not recruiting
  • Hodgkin Lymphoma
  • BrentuximabVedotin (BV)
  • Badalona, Barcelona, Spain
  • +14 more
Aug 12, 2020

Small Cell Lung Cancer Trial in Chengdu (PLM60)

Unknown status
  • Small Cell Lung Cancer
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jul 29, 2020

Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)

Completed
  • Acute Myelogenous Leukemia
  • Brentuximab Vedotin
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 12, 2020

Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 21, 2020

Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in Seattle

Completed
Has Results
  • Acute Biphenotypic Leukemia
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2019

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Leukemia, MDS Trial in Atlanta, Baltimore (bevacizumab, cytarabine, mitoxantrone HCl)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • bevacizumab
  • +2 more
  • Atlanta, Georgia
  • +2 more
Oct 15, 2019

Pain, Prostate Cancer, Quality of Life Trial in Canada (clodronate disodium, mitoxantrone HCl, prednisone)

Completed
  • Pain
  • +2 more
  • clodronate disodium
  • +3 more
  • Calgary, Alberta, Canada
  • +20 more
Apr 1, 2020

Medium Dose of Cytarabine and Mitoxantrone

Unknown status
  • Acute Myelogenous Leukemia
  • Chemotherapy
  • Flow Cytometer
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen
Jul 16, 2019

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023